Vivian T Thieu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Glycemic Control

Bariatric Surgery

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Julio Rosenstock, Clare J Lee, Laura Fernández Landó, Minzhi Liu, Chrisanthi A Karanikas, Vivian T Thieu
Impact on glycated haemoglobin and body weight changes after stopping tirzepatide for 4 weeks in the SURPASS-1 monotherapy trial. Diabetes, obesity & metabolism (2023)
Sue D Pedersen, Francesco Giorgino, Guillermo E Umpierrez, Vivian T Thieu, Angel Rodríguez, Claudia Nicolay, Laura Fernández Landó, Chrisanthi A Karanikas, Jacek Kiljanski
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme. Diabetes, obesity & metabolism (2023)
Ildiko Lingvay, Alice Yy Cheng, Joshua A Levine, Elisa Gomez-Valderas, Sheryl E Allen, Kari Ranta, Amelia Torcello Gómez, Vivian T Thieu
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies. Diabetes, obesity & metabolism 25 (4) (2022)
Ildiko Lingvay, Alice Yy Cheng, Joshua A Levine, Elisa Gomez-Valderas, Sheryl E Allen, Kari Ranta, Amelia Torcello Gómez, Vivian T Thieu
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies. Diabetes, obesity & metabolism (2022)
Ildiko Lingvay, Alice Yy Cheng, Joshua A Levine, Elisa Gomez-Valderas, Sheryl E Allen, Kari Ranta, Amelia Torcello-Gómez, Vivian T Thieu
Achievement of glycemic targets with weight loss and without hypoglycemia in type 2 diabetes with once-weekly GIP and GLP-1 receptor agonist tirzepatide: a post-hoc analysis of the SURPASS-1 to -5 studies. Diabetes, obesity & metabolism (2022)
Ildiko Lingvay, Alice Yy Cheng, Joshua A Levine, Elisa Gomez-Valderas, Sheryl E Allen, Kari Ranta, Amelia Torcello Gómez, Vivian T Thieu
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies. Diabetes, obesity & metabolism 25 (4) (2022)
Ildiko Lingvay, Alice Yy Cheng, Joshua A Levine, Elisa Gomez-Valderas, Sheryl E Allen, Kari Ranta, Amelia Torcello Gómez, Vivian T Thieu
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies. Diabetes, obesity & metabolism 25 (4) (2022)
Vivian T Thieu, Beth D Mitchell, Oralee J Varnado, Brian M Frier
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon. Diabetes, obesity & metabolism 22 (4) (2020)